NO326141B1 - Fremgangsmate for behandling av isolert systolisk hypertensjon - Google Patents

Fremgangsmate for behandling av isolert systolisk hypertensjon Download PDF

Info

Publication number
NO326141B1
NO326141B1 NO19995797A NO995797A NO326141B1 NO 326141 B1 NO326141 B1 NO 326141B1 NO 19995797 A NO19995797 A NO 19995797A NO 995797 A NO995797 A NO 995797A NO 326141 B1 NO326141 B1 NO 326141B1
Authority
NO
Norway
Prior art keywords
treatment
procedure
systolic hypertension
isolated systolic
isolated
Prior art date
Application number
NO19995797A
Other languages
English (en)
Other versions
NO995797L (no
NO995797D0 (no
Inventor
Eliot H Ohlstein
Giora Zeev Feuerstein
Robert R Ruffolo Jr
David P Brooks
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO995797L publication Critical patent/NO995797L/no
Publication of NO995797D0 publication Critical patent/NO995797D0/no
Publication of NO326141B1 publication Critical patent/NO326141B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fixed Capacitors And Capacitor Manufacturing Machines (AREA)

Claims (3)

1. Anvendelse av eprosartan for fremstilling av et medikament for behandling av isolert systolisk hypertensjon.
2. Anvendelse ifølge krav 1 hvor medikamentet er i form av en tablett eller kapsel.
3. Farmasøytisk blanding omfattende eprosartan og en farmasøytisk akseptabel bærer for behandling av isolert systolisk hypertensjon.
NO19995797A 1997-05-27 1999-11-26 Fremgangsmate for behandling av isolert systolisk hypertensjon NO326141B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4780097P 1997-05-27 1997-05-27
PCT/US1998/010794 WO1998053816A1 (en) 1997-05-27 1998-05-27 Method of treating isolated systolic hypertension

Publications (3)

Publication Number Publication Date
NO995797L NO995797L (no) 1999-11-26
NO995797D0 NO995797D0 (no) 1999-11-26
NO326141B1 true NO326141B1 (no) 2008-10-06

Family

ID=21951046

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995797A NO326141B1 (no) 1997-05-27 1999-11-26 Fremgangsmate for behandling av isolert systolisk hypertensjon

Country Status (24)

Country Link
US (1) US20020040045A1 (no)
EP (1) EP1003506B1 (no)
JP (1) JP2002500673A (no)
KR (1) KR20010013014A (no)
CN (1) CN1257427A (no)
AR (1) AR012872A1 (no)
AT (1) ATE307580T1 (no)
AU (1) AU740646B2 (no)
BR (1) BR9809611A (no)
CA (1) CA2288722C (no)
CZ (1) CZ298390B6 (no)
DE (1) DE69832075T2 (no)
ES (1) ES2251083T3 (no)
HU (1) HUP0003249A3 (no)
IL (1) IL132154A (no)
MX (1) MXPA99010970A (no)
NO (1) NO326141B1 (no)
NZ (1) NZ337888A (no)
PL (1) PL191971B1 (no)
SA (1) SA98190174B1 (no)
TR (1) TR199902914T2 (no)
TW (1) TW579296B (no)
WO (1) WO1998053816A1 (no)
ZA (1) ZA984421B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060160871A1 (en) * 2004-12-07 2006-07-20 Nektar Therapeutics Stable non-crystalline formulation comprising losartan

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US544080A (en) * 1895-08-06 Centrifugal filtering-machine
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
JPH05199342A (ja) * 1991-05-20 1993-08-06 Xerox Corp 無声の手書きによる携帯式通信装置および方法

Also Published As

Publication number Publication date
TR199902914T2 (xx) 2000-06-21
NO995797L (no) 1999-11-26
PL336886A1 (en) 2000-07-17
IL132154A (en) 2002-12-01
EP1003506A4 (en) 2000-11-29
KR20010013014A (ko) 2001-02-26
HUP0003249A3 (en) 2002-02-28
IL132154A0 (en) 2001-03-19
NZ337888A (en) 2001-04-27
WO1998053816A1 (en) 1998-12-03
HUP0003249A2 (hu) 2002-01-28
DE69832075T2 (de) 2006-07-13
EP1003506A1 (en) 2000-05-31
CZ420099A3 (cs) 2000-09-13
SA98190174B1 (ar) 2006-05-13
AR012872A1 (es) 2000-11-22
DE69832075D1 (de) 2005-12-01
EP1003506B1 (en) 2005-10-26
CN1257427A (zh) 2000-06-21
NO995797D0 (no) 1999-11-26
TW579296B (en) 2004-03-11
AU7601798A (en) 1998-12-30
US20020040045A1 (en) 2002-04-04
JP2002500673A (ja) 2002-01-08
BR9809611A (pt) 2000-07-04
CA2288722A1 (en) 1998-12-03
CZ298390B6 (cs) 2007-09-19
PL191971B1 (pl) 2006-07-31
AU740646B2 (en) 2001-11-08
ZA984421B (en) 1998-11-27
ES2251083T3 (es) 2006-04-16
MXPA99010970A (es) 2005-07-25
ATE307580T1 (de) 2005-11-15
CA2288722C (en) 2007-04-24

Similar Documents

Publication Publication Date Title
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
HUP0003173A2 (hu) A GLP-1 vagy analógjainak alkalmazása szívizominfarktus kezelésére használható gyógyszerkészítmények előállítására
NO883667D0 (no) Kapsel for farmasoeytisk virksomme innholdsstoffer av en droge.
CA2258095A1 (en) Tetrahydrolipstatin containing compositions
HUP0101598A2 (hu) Aszpartil proteáz inhibitorok prodrugjai és ezeket tartalmazó gyógyszerkészítmények
IT1245761B (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
IS1858B (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
HUP0000299A1 (hu) Késleltetett hatóanyag-leadású gyógyszerkészítmények
ATE81287T1 (de) Am zielorgan wirkendes enterales abgabesystem.
CA2307018A1 (en) Osmotic medicament releasing system
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
ATA285187A (de) Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel
ZA975827B (en) Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production.
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
CA2283408A1 (en) Swallow tablet comprising paracetamol
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
HUP9701777A2 (hu) Raloxifene alkalmazása mellrák megelőzésére alkalmas gyógyszerkészítmények előállítására
CA2350659A1 (en) Pharmaceutical composition for modified release insulin sensitiser
EP0302714A3 (en) Pharmaceutical composition for treatment of bone-wasting diseases
GR3017161T3 (en) Multi-fractionable tablet structure.
DE69627160D1 (de) Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma-butyrobetain für die behandlung von herz-gefäss-erkrankungen
WO2003099214A3 (en) Biguanide formulations
NO326141B1 (no) Fremgangsmate for behandling av isolert systolisk hypertensjon

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees